+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Roche Scholarship 2026

Roche UK

For young leaders in the NHS working to promote sustainable innovation or health equity.

Opening date: 16 March 2026

Application deadline: 6 May 2026

As a pioneer in healthcare, Roche UK focuses its energy and investment in developing transformative medicines and tests that improve the lives of people in the UK.

It is only by partnering with the leading minds in science and healthcare that we can best serve the needs of patients, particularly those from traditionally underserved communities. This is why Roche is committed to collaborative working with NHS organisations from across the United Kingdom.

As climate change poses a significant threat to our wellbeing, Roche recognises the inextricable connection between planetary and human health. That is why innovations in healthcare must be truly sustainable - for both the environment and society. Roche is committed to achieving Net Zero emissions globally by 2045 and halving the environmental impacts of its products and operations.

Roche is therefore proud to partner with One Young World again to launch the Roche Scholarship 2026, which will enable 3 outstanding professionals working in the NHS to participate in the One Young World Summit in Cape Town, South Africa from 3-6 November 2026.

Scholars will receive:

Access to the One Young World Summit 2026 in Cape Town.
Hotel accommodation in Cape Town in a private room between 2-6 November 2026 (inclusive).
The cost of travel to and from Cape Town (economy class).
- Scholars will be responsible for booking their own flights, and will be reimbursed.
Catering which includes breakfast, lunch, and dinner (provided by the hotel and during the Summit).
Cost of transportation between airport and hotel via public transport.
Candidate criteria
Aged 18 to 35* at the time of the One Young World Summit 2026.
Nationals of all countries will be eligible to apply for this scholarship, but must:
- Be based in the United Kingdom.
- Hold a position in the NHS or in an organisation working in partnership with the NHS.
Understanding of key local and/or global issues.
Track record of generating impactful and innovative solutions.
Demonstrated commitment to sustainable innovation in healthcare.

*We are not able to accept applications from those who will be aged under 18 at the time of the Summit.

Review of all submissions will be independent of the Roche portfolio and any clinical experience the submitter may have of Roche products.

AI Based Application Success Predictor

🔑 1. Alignment with Roche Therapeutic & Diagnostic Priorities (Top Predictor)

Roche UK strongly prioritizes proposals aligned with:

Pharmaceuticals

Oncology (major focus)
Immunology
Neuroscience
Rare diseases

Diagnostics

Precision medicine
Biomarkers & companion diagnostics
Digital health & data-driven diagnostics

👉 Proposals must clearly match Roche’s UK-specific priorities and ongoing portfolios

🎯 2. Patient-Centered & Real-World Impact

Roche places heavy emphasis on:

Improving patient outcomes
Real-world evidence (RWE)
Early diagnosis or treatment optimization

👉 Projects showing NHS impact or clinical pathway improvement perform significantly better

🏥 3. Relevance to the UK Healthcare System (Critical)

Successful proposals often demonstrate:

Integration with the National Health Service (NHS)
Feasibility within UK clinical settings
Benefits to UK patient populations

👉 Local relevance is a key differentiator vs global pharma grants

🤝 4. Strong Clinical or Academic Partnerships

High success rates are associated with:

NHS hospitals + academic collaborations
Multidisciplinary teams (clinicians + researchers + data scientists)

👉 Established UK networks significantly improve credibility

🧪 5. Robust Study Design & Feasibility

Clearly defined methodology
Realistic recruitment (especially within NHS)
Ethical and regulatory feasibility

👉 Weak feasibility is a common rejection reason

📊 6. Evidence Generation & Data Strategy

Roche favors projects that:

Generate real-world evidence (RWE)
Use registries, digital tools, or AI
Include clear endpoints and analytics plans

💊 7. Strategic Fit with Roche Pipeline

Strong proposals often:

Complement Roche’s existing drugs/diagnostics
Support:
- Earlier diagnosis
- Better patient stratification
- Treatment monitoring

👉 Strategic synergy is often decisive

💰 8. Transparent & Realistic Budget

Clearly justified costs
Efficient use of funds
Alignment with study scope

📑 9. Compliance & Ethical Governance

Full compliance with:
- UK research regulations
- Ethics approvals
- Data protection (GDPR)

👉 Non-compliance = automatic rejection risk

👩‍⚕️ 10. Investigator & Institutional Strength

Strong publication or clinical research record
Experience with industry-funded or NHS-based studies
Access to patient cohorts

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Alignment with Roche UK priorities (oncology, diagnostics)
Patient/NHS impact
Strategic fit with Roche pipeline

Moderate predictors:
4. Clinical feasibility within NHS
5. Partnerships (NHS + academia)
6. Data/RWE strategy

Supporting factors:
7. Investigator track record
8. Budget clarity
9. Compliance

💡 Insider Insight

Compared to other pharma funders:

👉 Roche UK places exceptional emphasis on diagnostics + real-world data

Projects combining drug + diagnostic + data have higher success
NHS integration is often the deciding factor

Specialties

Health Disparities

Public Health

Others

Eligibility Requirements

This programme is for young leaders within the NHS who have demonstrated a commitment to sustainable innovation in healthcare. Examples may include (but are not limited to) the following:

Tackling the causes and effects of health inequalities
Creating or implementing innovative methods of treatment or diagnosis to enhance the patient care pathway
Reducing emissions or burdens on natural resources, such as through decarbonising healthcare supply chains

Eligible Countries:

United Kingdom

Sponsor Details

Sponsor Institute/Organizations: Roche UK

Sponsor Type: Corporate/Non-Profit

Address: 14 Irving Street London, WC2H 7AF +44 (0)20 3691 8060

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity